COMMUNIQUÉS West-GlobeNewswire

Precision Optics Corporation Acquires Ross Optical Industries
08/07/2019
Strategic acquisition expands Precision Optics’ product offering and presence within the U.S. defense sector Company closes $950,000 equity raise tied to acquisition GARDNER, Mass., July 08, 2019 (GLOBE NEWSWIRE) -- [...]
Coherus BioSciences to Report Second Quarter Financial Results on August 1st
08/07/2019
REDWOOD CITY, Calif., July 08, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or “the Company”, Nasdaq: CHRS), today announced that its second quarter 2019 financial results will be released after market [...]
Therapeutic Solutions International Develops Glucoraphanin + NanoStilbene Encapsulated product for reduction of Prostate Specific Antigen (PSA)
08/07/2019
OCEANSIDE, Calif., July 08, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutic Solutions International, Inc., ( OTC Markets: TSOI ) announced today the development of a broccoli sprout extract containing the [...]
Y-mAbs Announces Successful Pre-BLA Meeting with FDA for Naxitamab
08/07/2019
NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel [...]
Novo Nordisk A/S - Share repurchase programme
08/07/2019
Bagsværd, Denmark, 8 July 2019 – On 7 May 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) [...]
Sunesis Pharmaceuticals Announces Executive Promotions and Provides Clinical Update
08/07/2019
300 mg Cohort of Phase 1b/2 Trial of Vecabrutinib now Enrolling SOUTH SAN FRANCISCO, Calif., July 08, 2019 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced the promotion of Judy Fox, Ph.D [...]
Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits
08/07/2019
Top-line Results Projected to be Available September 2019 CALGARY, Alberta, July 08, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) is pleased to announce today that all patients [...]
CorMedix Announces Publication of Taurolidine Pre-Clinical Oncology Data in “Investigational New Drugs” Journal
08/07/2019
BERKELEY HEIGHTS, N.J., July 08, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment [...]
Progenics Urges Shareholders to Vote Today “FOR” the Highly Qualified Director Candidates on the WHITE Proxy Card
08/07/2019
The Progenics 2019 Annual Meeting is July 11, 2019 NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative targeted medicines and artificial [...]
BioHemp International, Inc. (OTC: BKIT) Announces Deal to Private Label Water From American Premium Water Corporation (OTC: HIPH)
08/07/2019
New Private Label Water To Be Sold Exclusively On BKIT’s Channels NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – BioHemp International, Inc. (OTC: BKIT), (“Company”), a Company focused on consolidating [...]
ADMA Biologics Receives FDA Approval for License Transfers for BIVIGAM® and Nabi-HB®
08/07/2019
All Aspects of the Biotest Therapy Business Unit (“BTBU”) Acquisition Are Successfully Completed RAMSEY, N.J. and BOCA RATON, Fla., July 08, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “ [...]
Dentsply Sirona Announces Appointment of Jorge M. Gomez as Chief Financial Officer
08/07/2019
CHARLOTTE, N.C., July 08, 2019 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental Solutions Company, today announced the appointment of Jorge M. Gomez as Chief Financial Officer. [...]
Avid Bioservices Enters into Contract Manufacturing Agreements with New and Existing Customers
08/07/2019
Company Signs Top Ten Global Pharmaceutical Company as New Client and Expands Relationship with Existing Biotechnology Company Customer Agreements Include Process Transfer, Process Development and Clinical Manufacturing [...]
Organovo Presents Data on Creating Stem Cell-Based Bioprinted Kidney Organoids at the International Society for Stem Cell Research (ISSCR) 2019 Annual Meeting
08/07/2019
SAN DIEGO, July 08, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious diseases [...]
eSolutions Names Chris F. Hart Vice President, Product & Strategy
08/07/2019
OVERLAND PARK, Kan., July 08, 2019 (GLOBE NEWSWIRE) -- eSolutions, a leading provider of revenue cycle and workflow management technology, announced today that Chris F. Hart has joined the company as Vice President, [...]
Zogenix Completes Enrollment in Phase 3 Trial of FINTEPLA® in Lennox-Gastaut Syndrome
08/07/2019
EMERYVILLE, Calif., July 08, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it has completed enrollment for, and randomized [...]
HTG Expands Data Analytics Capabilities for Customers with the Release of HTG EdgeSeq Reveal Data Analytics Software Version 1.2.0
08/07/2019
TUCSON, Ariz., July 08, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced the release of its HTG EdgeSeq [...]
Syneos Health Schedules Second Quarter 2019 Earnings Call for Tuesday, August 6, 2019
08/07/2019
MORRISVILLE, N.C., July 08, 2019 (GLOBE NEWSWIRE) -- Syneos Health TM (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization combining a Contract Research Organization (CRO) and Contract [...]
REMINDER - TYME Presents Updated Data at ESMO GI 2019 from TYME-88-Panc Phase II Study Demonstrating Encouraging Overall Survival Trends in Patients with Advanced Pancreatic Cancer
08/07/2019
In this poor prognosis population, SM-88 demonstrated median overall survival (OS) of 6.4 months as of April 25, 2019 Efficacy indicators showed strong correlation with greater overall survival (OS). These indicators [...]

Pages